SMYD3 and malignant colon neoplasm: Michalis E. Sarris et al. provided solid evidence that SMYD3 can be recruited to its targets via multiple mechanisms, including interactions with trimethylated H3K4 tails, RNA Pol-II, or other sequence-specific binding proteins and required for liver and colon cancer development [23].